Elanco
Greenfield · Founded 1954
About Elanco
Elanco is a global leader in animal health, dedicated to improving the health and well-being of animals worldwide. The company develops, manufactures, and markets a wide range of innovative products designed to enhance the care of both companion animals and food animals. Elanco's portfolio includes vaccines, treatments, and preventive care solutions that support the health of pets, livestock, and poultry. With a vision of "food and companionship enriching life," Elanco strives to improve food security, enhance animal welfare, and foster stronger connections between people and animals. Through its commitment to sustainability, innovation, and collaboration, Elanco aims to create a healthier world for both animals and the people who depend on them.
Company Facts
- Founded: 1954
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 5,001 – 10,000
- Estimated revenue: $1M – $10M
- Total funding: $252.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2023)
- Ticker: nyse:ELAN
- Website: elanco.com
- Phone: +1 877-352-6261
Industries & Categories
Manufacturing, Pet, Supply Chain Management
Social Profiles
Canonical: https://fsome.com/organization/elanco-94000 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.